These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15571610)

  • 1. Discordance between beliefs and recommendations of gynecologic oncologists in ovarian cancer management.
    Chen L; Learman LA; Weinberg V; Powell CB
    Int J Gynecol Cancer; 2004; 14(6):1055-62. PubMed ID: 15571610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: survey results from members of the Society of Gynecologic Oncologists.
    Dewdney SB; Rimel BJ; Reinhart AJ; Kizer NT; Brooks RA; Massad LS; Zighelboim I
    Gynecol Oncol; 2010 Oct; 119(1):18-21. PubMed ID: 20673970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical practice of UK gynaecological oncologists in the treatment of primary advanced epithelial ovarian cancer (PAEOC): a questionnaire survey.
    Barton DP; Adib T; Butler J
    Gynecol Oncol; 2013 Nov; 131(2):347-51. PubMed ID: 23954901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?
    Eisenkop SM; Spirtos NM
    Gynecol Oncol; 2001 Sep; 82(3):489-97. PubMed ID: 11520145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients; results from a survey study in the Netherlands.
    Timmermans M; Sonke GS; van Driel WJ; Lalisang RI; Ottevanger PB; de Kroon CD; Van de Vijver KK; van der Aa MA; Kruitwagen RF
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():98-102. PubMed ID: 29525755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence of Primary Care Physicians to Evidence-Based Recommendations to Reduce Ovarian Cancer Mortality.
    Stewart SL; Townsend JS; Puckett MC; Rim SH
    J Womens Health (Larchmt); 2016 Mar; 25(3):235-41. PubMed ID: 26978124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current clinical practice in cytoreductive surgery for advanced ovarian cancer: a European survey.
    Cibula D; Verheijen R; Lopes A; Dusek L;
    Int J Gynecol Cancer; 2011 Oct; 21(7):1219-24. PubMed ID: 21892096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of neoadjuvant chemotherapy in the management of stage IIIC-IV ovarian cancer: survey results from the members of the European Society of Gynecological Oncology.
    Cornelis S; Van Calster B; Amant F; Leunen K; van der Zee AG; Vergote I
    Int J Gynecol Cancer; 2012 Mar; 22(3):407-16. PubMed ID: 22367320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring international differences in ovarian cancer treatment: a comparison of clinical practice guidelines and patterns of care.
    Norell CH; Butler J; Farrell R; Altman A; Bentley J; Cabasag CJ; Cohen PA; Fegan S; Fung-Kee-Fung M; Gourley C; Hacker NF; Hanna L; Høgdall CK; Kristensen G; Kwon J; McNally O; Nelson G; Nordin A; O'Donnell D; Schnack T; Sykes PH; Zotow E; Harrison S
    Int J Gynecol Cancer; 2020 Nov; 30(11):1748-1756. PubMed ID: 32784203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of subspecialty training on the management of advanced ovarian cancer.
    Eisenkop SM; Spirtos NM; Montag TW; Nalick RH; Wang HJ
    Gynecol Oncol; 1992 Nov; 47(2):203-9. PubMed ID: 1468698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility and Actual Use of European and Spanish Guidelines on the Management of Endometrial Cancer Among Gynecologic Oncologists in Spain.
    Zapardiel I; Blancafort C; Cibula D; Jaunarena I; Gorostidi M; Gil-Moreno A; De Santiago J;
    Int J Gynecol Cancer; 2017 Jul; 27(6):1293-1297. PubMed ID: 28604452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologists.
    Hamelinck VC; Stiggelbout AM; van de Velde CJH; Liefers GJ; Bastiaannet E
    Eur J Surg Oncol; 2017 Jul; 43(7):1288-1296. PubMed ID: 28258786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?
    Vergote I; Amant F; Leunen K
    Gynecol Oncol; 2010 Oct; 119(1):1-2. PubMed ID: 20833283
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.
    Mowery YM; Salama JK; Zafar SY; Moore HG; Willett CG; Czito BG; Hopkins MB; Palta M
    Cancer; 2017 Apr; 123(8):1434-1441. PubMed ID: 27984651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials.
    Rajagopal S; Goodman PJ; Tannock IF
    J Clin Oncol; 1994 Jun; 12(6):1296-304. PubMed ID: 8201392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical cytoreduction in ovarian cancer.
    McCreath WA; Chi DS
    Oncology (Williston Park); 2004 May; 18(5):645-53, discussion 653-4, 656, 658. PubMed ID: 15209191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucinous ovarian carcinoma: A survey of practice in Australia and New Zealand.
    Rajadevan N; Flinkier A; Saunders H; Lee YC; Scott C; Khaw P; Allan P; Davies C; Andrews J; Wilson M; Lombard JM; Harrison M; Nesfield H; DeFazio A; Meniawy T; Gorringe KL
    Aust N Z J Obstet Gynaecol; 2024 Aug; 64(4):319-325. PubMed ID: 38299485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy administration for ovarian cancer by gynecologic oncologists and medical oncologists.
    Berchuck A
    J Clin Oncol; 2007 Aug; 25(23):3552; author reply 3557-8. PubMed ID: 17687164
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
    Chan JK; Kapp DS; Shin JY; Husain A; Teng NN; Berek JS; Osann K; Leiserowitz GS; Cress RD; O'Malley C
    Obstet Gynecol; 2007 Jun; 109(6):1342-50. PubMed ID: 17540806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How American oncologists treat breast cancer: an assessment of the influence of clinical trials.
    Belanger D; Moore M; Tannock I
    J Clin Oncol; 1991 Jan; 9(1):7-16. PubMed ID: 1985172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.